New Insights Into Advanced Glycation End Products Induced Melanogenesis and Intervention Strategies
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70521 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Xi Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Estée Lauder Companies Innovation, Shanghai, China. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Melanins, Hyperpigmentation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Estée Lauder Companies.
Abstract (Originalsprache)
Background
Skin hyperpigmentation refers to areas of skin that become darker than the surrounding skin due to an increase in melanin production, which greatly impacts skin esthetics. UV exposure, intrinsic hormonal changes, or injury are the general causes of hyperpigmentation. Recently, studies indicated that advanced glycation end products (AGEs) contribute to hyperpigmentation. However, detailed mechanisms involved in this process as well as therapeutic solutions are yet to be explored.
Aims
This study aimed to investigate the underlying mechanisms as well as intervention strategies targeting AGEs‐induced melanogenesis.
Methods
The study exposed skin cells and 3D epidermal models to AGEs and measured melanin production and tyrosinase activity. Dimethoxytolyl propylresorcinol (DP), niacinamide, and green tea extract were tested for their ability to inhibit AGEs‐induced melanogenesis or related cytokines. The AGEs breaking efficacy of DP was assessed on glycated lysozyme by mass spectrometry, as well as on glycated skin cells and 3D full‐thickness skin models. Results and Conclusions Exposure to AGEs stimulates tyrosinase activity and melanin production in melanocytes and 3D melanocyte‐containing epidermal skin models. AGEs upregulate IL‐33 expression in fibroblasts via NLRP1/Caspase1 activation. DP was discovered to be an effective AGEs crosslink breaker and also capable of inhibiting AGEs induced melanin production in skin models. Moreover, niacinamide and green tea extract effectively inhibit IL‐18/IL‐33 secretion stimulated by AGEs. Those 3 components work collectively to target different stages of AGEs induced melanogenesis in skin and appear to be a potent intervention strategy to treat skin hyperpigmentation and sallowness issues during the aging process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Estée Lauder Companies Innovation, Shanghai, China.
- Clinique Laboratories, Melville, New York, USA.
- The Estée Lauder Research Laboratories, Melville, New York, USA.
ORCID-Profile: Jian Cao
Förderung
- Estée Lauder Companies
Zitieren
APA
Yang, X., You, M., Zhou, H., Li, Z., He, G., Mammone, T., Pernodet, N., & Cao, J. (2025). New Insights Into Advanced Glycation End Products Induced Melanogenesis and Intervention Strategies. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70521
Vancouver
Yang X, You M, Zhou H, Li Z, He G, Mammone T, et al. New Insights Into Advanced Glycation End Products Induced Melanogenesis and Intervention Strategies. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70521
BibTeX
@article{Yang2025,
author = {Yang, Xi and You, Mengqi and Zhou, Huanjun and Li, Zhen and He, Guangwen and Mammone, Thomas and Pernodet, Nadine and Cao, Jian},
title = {New Insights Into Advanced Glycation End Products Induced Melanogenesis and Intervention Strategies},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70521}
}
EUVIMED